Durata Therapeutics

^{Priced, Nasdaq: DRTX}

Developing Phase 3 antibiotic candidate for acute skin infections.

Industry: Health Care

First Day Return: +0.4%

DRTX

Developing Phase 3 antibiotic candidate for acute skin infections.

IPO News for Durata Therapeutics

Durata Therapeutics prices IPO at $9, below the range 07/18/12
5 US IPOs planned for the week of Jul 16 07/16/12
Durata Therapeutics sets terms for $75 million US IPO 07/09/12

IPO Data
IPO Date	07/18/2012
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$68
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.duratatherapeutics.com
Headquarters	Morristown, NJ, United States
Founded	2009
Employees at IPO	18

IPO News for Durata Therapeutics

Durata Therapeutics prices IPO at $9, below the range 07/18/12
5 US IPOs planned for the week of Jul 16 07/16/12
Durata Therapeutics sets terms for $75 million US IPO 07/09/12

Durata Therapeutics (DRTX) Performance